News from CNBC Business

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Tariffs Investors Ceo Stock Shares Earnings Stocks Eqs China Cet Nasdaq Investment Markets Wall Street Tesla Nvidia Inflation Trade Revenue Securities Stock Market Class Action Company Economy Bitcoin Federal Reserve Us Interest Rates Sales Prices Apple Pvr Sp 500 Ipo Trade War Crypto Amazon Companies German Securities Trading Act Shareholders Federal Securities Laws Gop Voting Rights Guidance Warren Buffett Monetary Policy Trading Elon Musk Securities Laws Berkshire Hathaway Otc Securities Trading Act Reserve Currency Credit Card Debt Taco Trade Encore Energy Rate Ose Teleflex Incorporated Skrybit

Filter by:

Gilead × U.S. × CNBC Business ×

CNBC Business • Jun 18, 2025

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new...

The approval of Gilead’s biannual HIV prevention injection presents a significant development in treatment options, though its impact may be influenced by possible reductions in go...

Read Full Article →